Skip to main content
Clinical Trials/NL-OMON48857
NL-OMON48857
Completed
Phase 4

Effectiveness in knee osteoarthritis of an intramuscular gluteal corticosteroid injection versus an intra-articular corticosteroid injection in general practice: a multicenter pragmatic randomized trial - Knee Osteoarthritis Injection Trial

Huisartsgeneeskunde0 sites140 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Huisartsgeneeskunde
Enrollment
140
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Huisartsgeneeskunde

Eligibility Criteria

Inclusion Criteria

  • 1\) contacted their general practitioner (consultation and/or repeat pain
  • medication prescription) due to knee osteoarthritis (ICPC L90 or L15 with
  • unequivocal diagnosis of osteoarthritis) during the past five years;
  • 2\) aged 45 years and over;
  • 3\) symptomatic knee osteoarthritis for at least 3 months prior to enrolment;
  • 4\) a minimum score of 3 on the numerical rating scale asking about the severity
  • of knee pain averaged over the last week (0\-10; 0\<\=no knee pain);
  • 5\) corticosteroid injection is indicated in this patient;
  • 6\) signed informed consent form., If a patient has bilateral knee
  • osteoarthritis, the most painful knee according to the patient will be selected

Exclusion Criteria

  • 1\) use of oral corticosteroids;
  • 2\) intra\-articular injection in a knee in the previous 6 months;
  • 3\) allergy to corticosteroids;
  • 4\) local or systemic infection, after recent vaccination with live attenuated
  • 5\) diabetes mellitus type 1, diabetes mellitus type 2 on insulin therapy,
  • poorly controlled diabetes mellitus type 2;
  • 6\) presence of inflammatory rheumatic diseases (such as rheumatoid arthritis,
  • psoriatic arthritis, spondylartropathies);
  • 7\) coagulopathy, use of anticoagulants, use of dual antiplatelet therapy;
  • 8\) a history of gastric/duodenal ulcer or a present gastric/duodenal ulcer;

Outcomes

Primary Outcomes

Not specified

Similar Trials